Meiji Yasuda Life Insurance Co Has $1.89 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Meiji Yasuda Life Insurance Co reduced its stake in HCA Healthcare by 17.1%, now holding 5,478 shares valued at approximately $1.89 million.
• HCA Healthcare has recently received mixed analyst ratings, with recommendations ranging from "Strong Buy" to "Hold", while its average target price is set at $401.83.
• The company reported earnings of $6.84 per share for the last quarter, exceeding expectations, with a revenue of $18.61 billion.

Meiji Yasuda Life Insurance Co cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 17.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,478 shares of the company's stock after selling 1,131 shares during the quarter. Meiji Yasuda Life Insurance Co's holdings in HCA Healthcare were worth $1,893,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in HCA. Brighton Jones LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at approximately $1,021,000. Cary Street Partners Financial LLC acquired a new stake in HCA Healthcare during the fourth quarter valued at approximately $187,000. Cetera Investment Advisers boosted its holdings in shares of HCA Healthcare by 21.6% in the 4th quarter. Cetera Investment Advisers now owns 29,171 shares of the company's stock worth $8,756,000 after acquiring an additional 5,187 shares in the last quarter. Humankind Investments LLC boosted its holdings in shares of HCA Healthcare by 15.3% in the 4th quarter. Humankind Investments LLC now owns 4,317 shares of the company's stock worth $1,296,000 after acquiring an additional 573 shares in the last quarter. Finally, Janus Henderson Group PLC raised its position in HCA Healthcare by 14.9% in the 4th quarter. Janus Henderson Group PLC now owns 1,538,826 shares of the company's stock worth $461,883,000 after purchasing an additional 199,188 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently weighed in on HCA. Wolfe Research cut shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. JPMorgan Chase & Co. boosted their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Royal Bank Of Canada reduced their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Finally, Barclays reduced their target price on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research note on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and an average target price of $401.83.

HCA Healthcare Trading Up 2.2%

HCA Healthcare stock opened at $420.68 on Monday. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The firm has a 50-day moving average of $380.14 and a 200-day moving average of $360.39. The company has a market cap of $98.43 billion, a price-to-earnings ratio of 17.68, a P/E/G ratio of 1.32 and a beta of 1.41. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $420.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.